| Literature DB >> 26347185 |
Jun Feng1,2, Yanyan Gu1, Yufen Quan1, Wei Zhang1, Mingfeng Cao3, Weixia Gao1, Cunjiang Song1, Chao Yang2, Shufang Wang4.
Abstract
Microbial levan is an important biopolymer with considerable potential in food and medical applications. Bacillus amyloliquefaciens NK-ΔLP strain can produce high-purity, low-molecular-weight levan, but production is relatively low. To enhance the production of levan, six extracellular protease genes (bpr, epr, mpr, vpr, nprE and aprE), together with the tasA gene (encoding the major biofilm matrix protein TasA) and the pgsBCA cluster (responsible for poly-γ-glutamic acid (γ-PGA) synthesis), were intentionally knocked out in the Bacillus amyloliquefaciens NK-1 strain. The highest levan production (31.1 g/L) was obtained from the NK-Q-7 strain (ΔtasA, Δbpr, Δepr, Δmpr, Δvpr, ΔnprE, ΔaprE and ΔpgsBCA), which was 103% higher than that of the NK-ΔLP strain (ΔpgsBCA) (15.3 g/L). Furthermore, the NK-Q-7 strain also showed a 94.1% increase in α-amylase production compared with NK-ΔLP strain, suggesting a positive effect of extracellular protease genes deficient on the production of endogenously secreted proteins. This is the first report of the improvement of levan production in microbes deficient in extracellular proteases and TasA, and the NK-Q-7 strain exhibits outstanding characteristics for extracellular protein production or extracellular protein related product synthesis.Entities:
Mesh:
Substances:
Year: 2015 PMID: 26347185 PMCID: PMC4561895 DOI: 10.1038/srep13814
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Figure 1Metabolic pathways associated with levan biosynthesis in Bacillus amyloliquefaciens and engineering strategies for levan production.
The red font indicates the genes deleted in this study and the corresponding deficient products. Metabolite symbols: Sucrose-6P, sucrose-6-phosphate; Bpr, bacillopeptidase F; Epr, extracellular serine protease; Mpr, extracellular metalloprotease; Vpr, extracellular serine protease; NprE, extracellular neutral metalloprotease; AprE, extracellular alkaline serine protease; TasA, major biofilm matrix protein; pgsBCA, poly-γ-glutamate synthase.
Figure 2Confirmation of gene deletions via PCR.
Chromosomal DNA served as the template for amplification. Lane M: DNA marker III; Lane WT: strains amplified with relevant detection primers using B. amyloliquefaciens NK-1 chromosomal DNA as the template; Lane MT: strains amplified with the relevant detection primers using chromosomal DNA from the gene deletion strains’ as the template.
Figure 3Cell pellicle formation in the B. amyloliquefaciens NK-1, B. amyloliquefaciens NK-P-1, B. amyloliquefaciens NK-Q-1 and B. amyloliquefaciens NK-ΔLP strains.
Cells were cultured at 30 °C for 72 h in MSgg broth in a six-well microtiter dish.
Figure 4γ-PGA fermentation results in the B. amyloliquefaciens NK-1 and mutant NK-P-X strains after 48 h of cultivation.
Values represent the means ± SD. Asterisks indicate significant difference from the NK-1 strain (P < 0.05). All cultures were repeated at least five times.
Figure 5Levan and α-amylase fermentation results in the B. amyloliquefaciens NK-ΔLP and mutant NK-Q-X strains.
(a) Comparison of levan production and dry cell weights between NK-ΔLP and the mutant strains after 48 h of cultivation. (b) Comparison of α-amylase production and dry cell weights between NK-ΔLP and the mutant strains after 48 h of cultivation. Values represent the means ± SD. Asterisks indicate significant difference from the NK-ΔLP strain (P < 0.05). All cultures were repeated at least five times.
Comparison of extracellular protease activity between the Bacillus amyloliquefaciens NK-ΔLP and Bacillus amyloliquefaciens NK-Q-X strains in levan fermentation medium.
| Strains | Extracellular protease activity (%) |
|---|---|
| NK-ΔLP | 100 ± 12.3 |
| NK-Q-1 | 104 ± 1.7 |
| NK-Q-2 | 62.1 ± 3.3 |
| NK-Q-3 | 50.5 ± 1.4 |
| NK-Q-4 | 55.6 ± 17.4 |
| NK-Q-5 | 54.6 ± 2.0 |
| NK-Q-6 | 44.2 ± 0.7 |
| NK-Q-7 | 14.3 ± 1.2 |
All cultures were repeated at least five times.
Asterisks indicate significant difference from the NK-ΔLP strain (P < 0.05).
Figure 6GPC results for γ-PGA and levan products.
(a) GPC spectrum of γ-PGA obtained from B. amyloliquefaciens NK-1 and (b) GPC spectrum of levan obtained from B. amyloliquefaciens NK-ΔLP.
Strains and plasmids used in this study.
| Strains and plasmids | Relevant genotype and characteristics | Source |
|---|---|---|
| wild type | (9) | |
| NK-1 derivative, Δ | This lab | |
| LL3 derivative, ΔpMC1, Δ | (42) | |
| NK-1 derivative, Δ | This work | |
| NK-1 derivative, Δ | This work | |
| NK-1 derivative, Δ | This work | |
| NK-1 derivative, Δ | This work | |
| NK-1 derivative, Δ | This work | |
| NK-1 derivative, Δ | This work | |
| NK-1 derivative, Δ | This work | |
| NK-P-1 derivative, Δ | This work | |
| NK-P-2 derivative, Δ | This work | |
| NK-P-3 derivative, Δ | This work | |
| NK-P-4 derivative, Δ | This work | |
| NK-P-5 derivative, Δ | This work | |
| NK-P-6 derivative, Δ | This work | |
| NK-P-7 derivative, Δ | This work | |
| F−, φ80d | This lab | |
| F−, | This lab | |
| Shuttle vector, temperature-sensitive (ts) replication origin, Ampr (gram-negative) and Cmr (gram-positive) | (45) | |
| pKSV7-derivation with | (46) | |
| p-KSU-derivation with deletion fragment of | This lab | |
| p-KSU-derivation with deletion fragment of | This work | |
| p-KSU-derivation with deletion fragment of | This work | |
| p-KSU-derivation with deletion fragment of | This work | |
| p-KSU-derivation with deletion fragment of | This work | |
| p-KSU-derivation with deletion fragment of | This work | |
| p-KSU-derivation with deletion fragment of | This work | |
| p-KSU-derivation with deletion fragment of | This work | |
Primers used in this study.
| Primers | Sequence (5′–3′) |
|---|---|
| tasA-SF | CCC |
| tasA-SR | CGTTCAGGAACGTTCTTGCTTTTTTGCTGTCTAATGTTTC |
| tasA-XF | ACAGCAAAAAAGCAAGAACGTTCCTGAACGATAATACATC |
| tasA-XR | GGG |
| tasA-SS | GACTGACGTCATGAGCTGCTGGGTTTTT |
| tasA-XX | CCAAGTTCTTTTTCACCGGGAACGCC |
| bpr-SF | CCCC |
| bpr-SR | TTATTTTTCACATTTCTTTTTCTTTTTCATAGTCTGCCTC |
| bpr-XF | ATGAAAAAGAAAAAGAAATGTGAAAAATAACAAGAC |
| bpr-XR | CCCC |
| bpr-SS | TAGACACGTATTTTCAGCGTGATCC |
| bpr-XX | GCTCGGAGGCTATTCAGTTGCGTAT |
| epr-SF | CGC |
| epr-SR | TAAGCGCTCGTATTCGTTCTCGTTACTGCAGG |
| epr-XF | CAGTAACGAGAACGAATACGAGCGCTTATTGG |
| epr-XR | AGGC |
| epr-SS | GCGGGTTTATCCTGTTCTTAATCGG |
| epr-XX | GGCACCGTTATTTTCTACAGCCTGG |
| mpr-SF | CCC |
| mpr-SR | CGTTCAGGAACGTTCTTGCTTTTTTGCTGTCTAATGTTTC |
| mpr-XF | ACAGCAAAAAAGCAAGAACGTTCCTGAACGATAATACATC |
| mpr-XR | GGG |
| mpr-SS | GACTGACGTCATGAGCTGCTGGGTTTTT |
| mpr-XX | CCAAGTTCTTTTTCACCGGGAACGCC |
| vpr-SF | CCCC |
| vpr-SR | TTATTTTTCACATTTCTTTTTCTTTTTCATAGTCTGCCTC |
| vpr-XF | ATGAAAAAGAAAAAGAAATGTGAAAAATAACAAGAC |
| vpr-XR | CCCC |
| vpr-SS | TAGACACGTATTTTCAGCGTGATCC |
| vpr-XX | GCTCGGAGGCTATTCAGTTGCGTAT |
| nprE-SF | CCCC |
| nprE-SR | TTATTTTTCACATTTCTTTTTCTTTTTCATAGTCTGCCTC |
| nprE-XF | ATGAAAAAGAAAAAGAAATGTGAAAAATAACAAGAC |
| nprE-XR | CCCC |
| nprE-SS | TAGACACGTATTTTCAGCGTGATCC |
| nprE-XX | GCTCGGAGGCTATTCAGTTGCGTAT |
| aprE-SF | CCCC |
| aprE-SR | TTATTTTTCACATTTCTTTTTCTTTTTCATAGTCTGCCTC |
| aprE-XF | ATGAAAAAGAAAAAGAAATGTGAAAAATAACAAGAC |
| aprE-XR | CCCC |
| aprE-SS | TAGACACGTATTTTCAGCGTGATCC |
| aprE-XX | GCTCGGAGGCTATTCAGTTGCGTAT |
The restriction enzyme cleavage sites are underlined.